Shares of Onconova Therapeutics Inc. (NASDAQ:ONTX) saw strong trading volume on Monday . 481,224 shares were traded during mid-day trading, an increase of 88% from the previous session’s volume of 256,652 shares.The stock last traded at $4.03 and had previously closed at $3.76.

Separately, Maxim Group reiterated a “buy” rating and issued a $6.00 price target on shares of Onconova Therapeutics in a research note on Friday. One research analyst has rated the stock with a hold rating and four have given a buy rating to the company. The stock presently has an average rating of “Buy” and a consensus price target of $24.74.

The firm has a 50-day moving average price of $4.04 and a 200 day moving average price of $4.74. The firm’s market capitalization is $24.79 million.

Onconova Therapeutics (NASDAQ:ONTX) last released its earnings results on Monday, August 15th. The biopharmaceutical company reported ($1.96) earnings per share for the quarter. The business earned $2.25 million during the quarter. On average, equities research analysts forecast that Onconova Therapeutics Inc. will post ($7.40) earnings per share for the current year.

Onconova Therapeutics, Inc is a clinical-stage biopharmaceutical company. The Company operates through the identification and development of oncology therapeutics segment. It is focused on discovering and developing small molecule drug candidates to treat cancer. The Company has created a targeted anti-cancer agents designed to work against specific cellular pathways that are important to cancer cells.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.